Nyxoah Statistics
Total Valuation
Nyxoah has a market cap or net worth of $118.27 million. The enterprise value is $108.68 million.
Important Dates
The last earnings date was Thursday, March 19, 2026, after market close.
| Earnings Date | Mar 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Nyxoah has 37.54 million shares outstanding. The number of shares has increased by 16.38% in one year.
| Current Share Class | 43.03M |
| Shares Outstanding | 37.54M |
| Shares Change (YoY) | +16.38% |
| Shares Change (QoQ) | +7.16% |
| Owned by Insiders (%) | 19.00% |
| Owned by Institutions (%) | 14.15% |
| Float | 23.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.83 |
| Forward PS | 3.58 |
| PB Ratio | 2.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.25, with a Debt / Equity ratio of 0.86.
| Current Ratio | 1.25 |
| Quick Ratio | 1.14 |
| Debt / Equity | 0.86 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.25 |
Financial Efficiency
Return on equity (ROE) is -110.95% and return on invested capital (ROIC) is -45.95%.
| Return on Equity (ROE) | -110.95% |
| Return on Assets (ROA) | -37.69% |
| Return on Invested Capital (ROIC) | -45.95% |
| Return on Capital Employed (ROCE) | -120.10% |
| Weighted Average Cost of Capital (WACC) | 11.84% |
| Revenue Per Employee | $64,078 |
| Profits Per Employee | -$576,094 |
| Employee Count | 184 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 0.79 |
Taxes
In the past 12 months, Nyxoah has paid $1.18 million in taxes.
| Income Tax | 1.18M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.27% in the last 52 weeks. The beta is 0.62, so Nyxoah's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -72.27% |
| 50-Day Moving Average | 4.31 |
| 200-Day Moving Average | 5.59 |
| Relative Strength Index (RSI) | 31.69 |
| Average Volume (20 Days) | 68,372 |
Short Selling Information
The latest short interest is 269,125, so 0.72% of the outstanding shares have been sold short.
| Short Interest | 269,125 |
| Short Previous Month | 237,379 |
| Short % of Shares Out | 0.72% |
| Short % of Float | 1.13% |
| Short Ratio (days to cover) | 4.69 |
Income Statement
In the last 12 months, Nyxoah had revenue of $11.76 million and -$105.77 million in losses. Loss per share was -$2.78.
| Revenue | 11.76M |
| Gross Profit | 7.43M |
| Operating Income | -98.02M |
| Pretax Income | -104.59M |
| Net Income | -105.77M |
| EBITDA | -96.71M |
| EBIT | -98.02M |
| Loss Per Share | -$2.78 |
Full Income Statement Balance Sheet
The company has $56.36 million in cash and $49.40 million in debt, with a net cash position of $6.96 million or $0.19 per share.
| Cash & Cash Equivalents | 56.36M |
| Total Debt | 49.40M |
| Net Cash | 6.96M |
| Net Cash Per Share | $0.19 |
| Equity (Book Value) | 57.68M |
| Book Value Per Share | 1.44 |
| Working Capital | 14.39M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.30M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | 63.13% |
| Operating Margin | -833.18% |
| Pretax Margin | -888.98% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Nyxoah does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.38% |
| Shareholder Yield | -16.38% |
| Earnings Yield | -91.47% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for Nyxoah is $11.25, which is 257.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.25 |
| Price Target Difference | 257.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 107.46% |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |